RHEP — Regional Health Properties Income Statement
0.000.00%
- $4.58m
- $45.91m
- $18.34m
- 45
- 96
- 36
- 61
Annual income statement for Regional Health Properties, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17.6 | 26.7 | 35.9 | 17.2 | 18.3 |
Cost of Revenue | |||||
Gross Profit | — | 17.4 | 15.5 | 7.96 | 8.89 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 15.3 | 24 | 43.2 | 18 | 18.2 |
Operating Profit | 2.29 | 2.72 | -7.27 | -0.804 | 0.161 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.604 | -1.14 | -6.87 | -3.89 | -3.22 |
Net Income After Taxes | -0.604 | -1.14 | -6.87 | -3.89 | -3.22 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.688 | -1.18 | -6.87 | -3.89 | -3.22 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -9.69 | -10.2 | -15.9 | 39.5 | -3.22 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -5.69 | -5.93 | -7.07 | 21 | -1.42 |